Higuchi T, Kanzaki H, Iwai M, Narukawa S, Fujita J, Mori T
Faculty of Medicine, Kyoto University, Japan.
Fertil Steril. 1995 Jan;63(1):52-7. doi: 10.1016/s0015-0282(16)57296-3.
To investigate the expression of messenger RNA (mRNA) for gonadal steroid hormone receptors in the human pelvic peritoneum.
Analysis of estrogen receptor (ER), progesterone receptor (PR), and androgen receptor (AR) mRNA expressions in the pelvic peritoneum was carried out using the quantitative reverse transcription-polymerase chain reaction (PCR) method.
Department of Gynecology and Obstetrics, Kyoto University Hospital, Kyoto, Japan.
Pelvic peritoneal tissues from patients with (n = 10) and without (n = 10) endometriosis who had undergone gynecological surgery were studied.
Estrogen receptor, PR, and AR mRNAs were detected in all pelvic peritoneal samples analyzed. In the pelvic peritoneum of patients without endometriosis, ER mRNA levels were significantly lower in the luteal phase than in the follicular phase. This cyclic profile of ER mRNA expression was not observed in the pelvic peritoneum of patients with endometriosis. During the follicular phase, ER mRNA levels in the pelvic peritoneum of patients with endometriosis were significantly lower than those of patients with endometriosis. Neither PR nor AR mRNA levels in the pelvic peritoneum of either patient group showed significant cyclic variations throughout the menstrual cycle. A comparison of PR and AR mRNA levels in the pelvic peritoneum of the endometriosis and the nonendometriosis groups revealed no significant differences.
These data indicate a decrease in ER gene expression in the pelvic peritoneum of patients with endometriosis during the follicular phase. This suggests that the possible responsiveness of peritoneal cells to estrogen may be related to the occurrence and/or development of endometriosis.
研究性腺甾体激素受体信使核糖核酸(mRNA)在人盆腔腹膜中的表达。
采用定量逆转录聚合酶链反应(PCR)法分析盆腔腹膜中雌激素受体(ER)、孕激素受体(PR)和雄激素受体(AR)mRNA的表达。
日本京都京都大学医院妇产科。
对接受妇科手术的有(n = 10)和无(n = 10)子宫内膜异位症患者的盆腔腹膜组织进行研究。
在所有分析的盆腔腹膜样本中均检测到雌激素受体、PR和AR mRNA。在无子宫内膜异位症患者的盆腔腹膜中,黄体期ER mRNA水平显著低于卵泡期。在子宫内膜异位症患者的盆腔腹膜中未观察到ER mRNA表达的这种周期性变化。在卵泡期,子宫内膜异位症患者盆腔腹膜中的ER mRNA水平显著低于无子宫内膜异位症患者。两组患者盆腔腹膜中的PR和AR mRNA水平在整个月经周期中均未显示出明显的周期性变化。子宫内膜异位症组和非子宫内膜异位症组盆腔腹膜中PR和AR mRNA水平的比较未发现显著差异。
这些数据表明,卵泡期子宫内膜异位症患者盆腔腹膜中ER基因表达降低。这表明腹膜细胞对雌激素的可能反应性可能与子宫内膜异位症的发生和/或发展有关。